https://scholars.lib.ntu.edu.tw/handle/123456789/638442
標題: | Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trial | 作者: | Soo, Ross A Huat Tan, Eng Hayashi, Hidetoshi Seto, Takashi CHIA-CHI LIN Ou, Sai-Hong Ignatius Kim, Dong-Wan Liu, Geoffrey Abbattista, Antonello Martini, Jean-François Hooi Wong, Chew Toffalorio, Francesca Solomon, Benjamin J |
關鍵字: | Anaplastic lymphoma kinase; Asian; Lorlatinib; Non-small cell lung cancer; Tyrosine kinase inhibitor | 公開日期: | 七月-2022 | 卷: | 169 | 來源出版物: | Lung cancer (Amsterdam, Netherlands) | 摘要: | To analyze the efficacy and safety of lorlatinib in Asian and non-Asian patients with pretreated anaplastic lymphoma kinase (ALK)-positive, advanced non-small cell lung cancer (NSCLC) from a phase 1/2 study. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/638442 | ISSN: | 01695002 | DOI: | 10.1016/j.lungcan.2022.05.012 |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。